Back

Human embryonic stem cell-derived cardiac progenitor cells improve contractile function of long-term cultured failing human myocardium

29 August 2026 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: Novel approaches to mending the heart Stem Cells, Cell Cycle, Cell Senescence, Cell Death ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kun Lu

University Hospital of Munich, Munich (Germany)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on novel approaches to mending the heart
Professor M. Giacca (London, GB)
Slides Video
Presentation thumbnail
Targeting fibrotic regions for in situ cardiac regeneration
Doctor Y. Jiang (Shenzhen, CN)
Abstract Slides Video
Presentation thumbnail
Co-targeting fibroblast mechanotransduction and cardiomyocyte metabolism wtih a Src family kinase inhibitor as a strategy to treat heart failure
Mr D. Nishijo (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel approaches to mending the heart
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Living myocardial slices as a model for testing cardiac pro-reparative gene therapies
29 August 2026
thumbnail
Congress Presentation
Engineered epicardial cells from human embryonic stem cells promote engraftment and maturation of human cardiac progenitor cells in the rodent and porcine model
14 May 2024
thumbnail
Congress Presentation
Cardiac organoids as regenerative therapy in a preclinical model of acute myocardial infarction-Corrected version
29 August 2025
thumbnail
Congress Presentation
Cell therapy in heart failure: lessons learned and future directions
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources